A Phase 1/1b Study Evaluating Trametinib Plus Docetaxel or Pemetrexed in Patients With Advanced Non-Small Cell Lung Cancer. [electronic resource]
Producer: 20171121Description: 556-566 p. digitalISSN:- 1556-1380
- Adenocarcinoma -- drug therapy
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Carcinoma, Large Cell -- drug therapy
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Carcinoma, Squamous Cell -- drug therapy
- Docetaxel
- Female
- Follow-Up Studies
- Humans
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Neoplasm Staging
- Pemetrexed -- administration & dosage
- Prognosis
- Pyridones -- administration & dosage
- Pyrimidinones -- administration & dosage
- Survival Rate
- Taxoids -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.